STERIS plc $STE Shares Sold by APG Asset Management N.V.

APG Asset Management N.V. reduced its position in STERIS plc (NYSE:STE) by 9.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,428,053 shares of the medical equipment provider’s stock after selling 145,679 shares during the quarter. STERIS comprises approximately 0.6% of APG Asset Management N.V.’s investment portfolio, making the stock its 21st biggest holding. APG Asset Management N.V. owned about 1.45% of STERIS worth $353,357,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in STE. Vanguard Group Inc. grew its stake in STERIS by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 12,213,521 shares of the medical equipment provider’s stock worth $3,022,114,000 after buying an additional 50,393 shares during the last quarter. State Street Corp boosted its holdings in STERIS by 2.4% in the second quarter. State Street Corp now owns 4,188,103 shares of the medical equipment provider’s stock worth $1,006,069,000 after acquiring an additional 98,220 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of STERIS by 1.9% during the second quarter. Geode Capital Management LLC now owns 2,479,108 shares of the medical equipment provider’s stock worth $592,980,000 after acquiring an additional 46,859 shares during the last quarter. Orbis Allan Gray Ltd grew its stake in shares of STERIS by 36.0% during the second quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after acquiring an additional 556,088 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of STERIS by 16.4% during the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider’s stock valued at $387,797,000 after acquiring an additional 221,199 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on STE shares. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $275.20.

STERIS Stock Down 0.9%

STERIS stock opened at $252.36 on Friday. The business’s 50-day moving average price is $255.83 and its 200 day moving average price is $251.73. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The firm has a market cap of $24.75 billion, a price-to-earnings ratio of 35.20 and a beta of 1.03. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same quarter in the previous year, the business posted $2.32 EPS. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. As a group, sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be given a $0.63 dividend. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s dividend payout ratio is 35.15%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.